マルチウビキチン鎖受容体は,ウビキチン-プロテアゾーム系における基質選択性の層を定義する
Rati Verma1, Robert Oania, Johannes Graumann
1Howard Hughes Medical Institute, California Institute of Technology, Pasadena, CA 91125, USA.
Cell
|July 10, 2004
まとめ
Rad23やRpn10のようなマルチウビキチン鎖結合タンパク質 (MCBP) は,26Sプロテアソームにウビキチン化タンパク質を勧誘する上で極めて重要です. 彼らの特定の役割は,ユビキチン-プロテアソームシステム (UPS) 内の基板選択性を保証します.
科学分野:
- 細胞生物学 細胞生物学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- ウビキチン-プロテアソームシステム (UPS) は,タンパク質の分解に不可欠です.
- ユビキチン化タンパク質を26Sプロテアソームに誘導することは,重要なステップです.
- この過程におけるRad23とRpn10のマルチチュービキチン鎖結合タンパク質 (MCBPs) の役割は議論されている.
研究 の 目的:
- 生物化学的にRad23とRpn10が26Sプロテアソームによるユビキチン化基質の徴集と分解における役割を調査する.
- UPSにおける基質選択性に対するMCBPの具体的な貢献を明らかにする.
主な方法:
- ユビキチン化Cdk阻害剤Sic1 (UbSic1) を使用したインビトロ分解アッセイ.
- 野生型および変異型プロテアソーム (rpn10Δ,rad23Δ) を用いて分解の分析.
- 発見を確認し,複数のUPS基板の回転を評価するために,in vivo実験を行います.
主要な成果:
- Rpn10またはRad23が欠けていた変異タンパク質は,UbSic1.1.の結合および分解が損なわれたことを示した.
- Rpn10とRad23の両方が,突然変異したプロテアソームへのUbSic1のリクルートメントを回復することができました.
- Rad23による劣化救済は,Rpn10のVWAドメインの必要性を強調しました.
- インビボ試験では,Rad23とRpn10のマルチウビキチン結合ドメインがSic1分解に寄与することを確認した.
- サブストラットのターンオーバー研究により,異なるUPSのサブストラットに対する特定のMCBP要件が明らかになりました.
結論:
- Rad23とRpn10は,26Sプロテアソームによるユビキチン化基質の徴募と分解において,本質的に異なる役割を果たしています.
- Rpn10のVWAドメインとRpn10のマルチウビキチン結合ドメインは,効率的な分解に不可欠です.
- MCBP媒介の基板募集は,ユビキチン-プロテアゾーム系に特異性の追加層を提供します.
関連する概念動画
Heart Failure V: Medical Management
224
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
224
Myocarditis III: Medical Management
179
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
179
Endocarditis III: Medical Management
217
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
217
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
31.1K
This study presents a novel device that offers an easy route to quickly provide medications and fluids in patients with limited or difficult IV access. This small-diameter device is placed in the distal third of the rectum, allowing for ongoing medication and fluids...
31.1K
Inhaled Medications
757
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
757
Preparing and Administering Inhaled Medications
38.2K
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT
Inhaled medications are prescribed for conditions affecting the bronchi, which branch off of the trachea, and bronchioles, which are progressively smaller conducting airways spread throughout the lung tissue. These conditions can be classified as acute (i.e., temporary, with quick onset) or chronic (i.e., persistent and/or recurrent symptoms lasting months to years). Common acute conditions...
Inhaled medications are prescribed for conditions affecting the bronchi, which branch off of the trachea, and bronchioles, which are progressively smaller conducting airways spread throughout the lung tissue. These conditions can be classified as acute (i.e., temporary, with quick onset) or chronic (i.e., persistent and/or recurrent symptoms lasting months to years). Common acute conditions...
38.2K
